Epitech Research SRL
Epitech Research reported total assets of 132,574 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jul 2026).
The score of Epitech Research shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +177 % Total assets +122 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Epitech Research's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 08 Jul 2025
- Year ended 31 Dec 2023filed on 06 Jun 2024
Epitech Research's financial analysis
- Solvency87.0%sector median: 45.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Epitech Research
Epitech Research's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0798.532.110
- VAT number
- BE0798532110
- Peppol
- Registered · 0208:0798532110 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Feb 2023
- Registered office
- 1160 Auderghem
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Epitech Research (SRL) has been based in Auderghem since 2023, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 42,836 € and equity of 115,399 €; its revenue is not published. Its solvency stands at 87.0%, above the median of its sector (45.7%).
Companies similar to Epitech Research
Companies in the same business, of comparable size and area, outside its group.
- Strouwen Statistics Research and experimental development on natural sciences and engineering Hasselt · balance sheet 268,681 €
- Huysse MedConsult Research and experimental development on natural sciences and engineering Boutersem · balance sheet 144,769 €
- Biokey Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 2,606 €
- LP Engineering Research and experimental development on natural sciences and engineering Liège · balance sheet 138,903 €
- Pxlence Research and experimental development on natural sciences and engineering Ghent · balance sheet 147,731 €
- MDC Kestens Research and experimental development on natural sciences and engineering Lille · balance sheet 140,827 €
- MDSH Research and experimental development on natural sciences and engineering Ixelles · balance sheet 92,229 €
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
Frequently asked questions about Epitech Research
What is the revenue of Epitech Research?
Epitech Research files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Epitech Research?
In Belgium, the VAT number is the company number prefixed with BE: BE0798532110 for Epitech Research, if the company is VAT-registered. Its company number (CBE) is 0798.532.110.
Where is the registered office of Epitech Research?
According to the CBE register, the registered office of Epitech Research is in 1160 Auderghem.
What is the equity of Epitech Research?
At the close of the 2025 financial year, the equity of Epitech Research amounts to 115,399 €, a solvency of 87.0% of total assets.
Who manages Epitech Research?
The register lists 1 active mandates at Epitech Research. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Epitech Research
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →